[OPNT] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[OPNT] Opiant Pharmaceuticals, Inc.
Announcement Date
12-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 435.65%
YoY- -93.21%
Quarter Report
OPNT's Result
OPNT's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 31/10/17 31/10/16 CAGR
Revenue 173,874 14,041 8,601 20,494 4,248 22 1,121 134.51%
PBT -9,908 3,417 725 10,684 -918 -5,633 -601 60.57%
Tax 9 548 -6 -24 -20 -34 -19 -
NP -9,917 3,417 725 10,684 -918 -5,633 -601 60.59%
Tax Rate - -16.03% 0.85% 0.22% - - - -
Total Cost 183,791 10,624 7,876 9,810 5,166 5,655 1,722 120.16%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 31/10/17 31/10/16 CAGR
NP Margin -5.70 24.34 8.43 52.13 -21.61 -25,604.55 -53.57 -31.51%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 31/10/17 31/10/16 CAGR
EPS -1.93 0.77 0.17 2.64 -0.32 -2.77 -0.30 36.96%
EPS Diluted -1.93 0.56 0.15 1.97 -0.32 -2.77 -0.30 36.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.